CMS
60
2
KHC
9
-4
STT
64
2
FITB
60
-5
GOOG
57
-6
MTCH
20
-8
HSY
31
-6
CFG
74
2
CSCO
58
-2
NWS
75
-4
XEL
67
2
DNB
74
-6
XOM
42
-6
VRTX
47
-6
JNPR
50
-6
HRB
59
2
MCHP
34
-2
SE
60
-3
ESS
62
-3
TROW
47
-6
CMS
60
2
KHC
9
-4
STT
64
2
FITB
60
-5
GOOG
57
-6
MTCH
20
-8
HSY
31
-6
CFG
74
2
CSCO
58
-2
NWS
75
-4
XEL
67
2
DNB
74
-6
XOM
42
-6
VRTX
47
-6
JNPR
50
-6
HRB
59
2
MCHP
34
-2
SE
60
-3
ESS
62
-3
TROW
47
-6
Financhill
Back

JPMorgan Equity Premium Income ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
49

JEPI
JPMorgan Equity Premium Income ETF

Last Price:
59.26
Seasonality Move:
0.62%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
49
JPMorgan Equity Premium Income ETF (JEPI) is a Sell

Is JPMorgan Equity Premium Income ETF a Buy, Sell or Hold?

  • The current JPMorgan Equity Premium Income ETF [JEPI] share price is $59.27. The Score for JEPI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • JEPI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JEPI Stock Price Chart

What is JPMorgan Equity Premium Income ETF's stock price today?

  • The JPMorgan Equity Premium Income ETF share price today is $59.27
    The current trend is moderately bearish and JEPI is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

JEPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 47.74 Sell
Chaikin Money Flow: -2650530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.01 - 59.93) Sell
Bollinger Bands (100): (56.84 - 59.44) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

JEPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.8 Sell
20-day SMA: 59.4 Sell
50-day SMA: 59.24 Buy
200-day SMA: 57.4 Buy
8-day EMA: 59.63 Sell
20-day EMA: 59.48 Sell
50-day EMA: 59.09 Buy
200-day EMA: 57.54 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

JPMorgan Equity Premium Income ETF Earnings Growth & JEPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

JPMorgan Equity Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):